AYI options traders turn sharply bullish as analyst targets slide
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Options positioning on AYI just hit its most bullish extreme in at least 52 weeks. The put-call ratio fell to 0.18 on October 19, 2.68 standard deviations below its 20-day mean of 0.68. That is a dramatic swing: two weeks ago the PCR sat above 0.80, where it had been anchored for most of the past month.
The stock rose 4.2% over the past week. That compares to a median decline of 3.6% for its closest peers, including AME, EMR, and HUBB.
Analysts cutting targets, traders buying calls
The options shift runs against a recent wave of analyst price-target reductions. Morgan Stanley's Chris Snyder cut his target this morning from $410 to $380, while maintaining an Overweight rating. Oppenheimer trimmed to $415 from $440 on October 8. Baird lowered twice, ending at $348. William Blair downgraded the stock to Market Perform in late September. The consensus target now sits at $370, against a current price of $308.58.
That $61 gap implies 19.8% upside from here. Options traders appear to be leaning into it. The 52-week low on the PCR is 0.09, so today's 0.18 is near the most call-skewed the market has seen, though not at the absolute floor.
Borrowing costs rise but the lending market is not tight
Short interest sits at 3.35% of free float, up 11.1% over the week but down 21.2% on the day, a noisy single-session reading that likely reflects settlement timing. The direction over the past month is a modest 4.6% increase. Cost to borrow rose 66% over the week to 0.57%, which sounds alarming in percentage terms but the absolute level remains low. Availability stands at 4,152%, meaning there are more than 41 shares available to borrow for every one currently lent out. The lending market for AYI is loose, not stressed.
FMR LLC holds 10.9% of shares and added roughly 962,000 shares as of September 30. That is a material build from a large active manager. AQR added around 838,000 shares in the quarter to June. Those accumulation figures provide some institutional backdrop to the call-heavy positioning in options.
What to watch
The next earnings date is January 8, 2027, 80 days away. Wikipedia attention for AYI is running at a z-score of 2.32 against its own 90-day history, the highest retail attention reading in the alt data. The specific price to track is $370, the current consensus target: whether analysts revise further below the stock price or hold here will tell you whether today's call positioning is being validated or challenged.
Data summary
- PCR: 0.18, z-score -2.68 vs 20-day mean, 52-week low is 0.09
- Short interest: 3.35% of free float, +11.1% over 1 week
- Cost to borrow: 0.57%, +66% over 1 week; availability at 4,152%
- Price: $308.58, +4.2% on the week vs peer median -3.6%
- Morgan Stanley target cut to $380 (from $410) today; consensus $370.17
- Next earnings: January 8, 2027
Stocks in this article
See the live data behind this article on ORTEX.
Open AYI on ORTEX →How this article was generated
- Generated
- 20 Oct 2026, 18:19
- Data as of
- 20 Oct 2026, 18:16
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.